We are live on
!
Find out more
MAG
Millrace Asset Group Portfolio holdings
AUM
$98.4M
1-Year Est. Return
63.71%
This Fund
S&P 500
This Quarter
Est. Return
+14.57%
1 Year Est. Return
+63.71%
3 Year Est. Return
+112.82%
5 Year Est. Return
+625.06%
10 Year Est. Return
+4,658.38%
AUM
$88.1M
AUM Growth
+$8.94M
(+11%)
Cap. Flow
+$2.94M
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
40.39%
Holding
66
New
14
Increased
20
Reduced
14
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$2.54M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$2.54M |
| 3 |
Extreme Networks
EXTR
|
+$2.02M |
| 4 |
DocGo
DCGO
|
+$2.01M |
| 5 |
Azenta
AZTA
|
+$1.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Castle Biosciences
CSTL
|
+$1.65M |
| 2 |
Identive
INVE
|
+$1.56M |
| 3 |
AtriCure
ATRC
|
+$1.45M |
| 4 |
LFG
Archaea Energy Inc.
LFG
|
+$1.4M |
| 5 |
Babcock & Wilcox
BW
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.27% |
| 2 | Healthcare | 22.85% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Industrials | 11.09% |
| 5 | Consumer Staples | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Babcock & Wilcox
BW
$1.05B
| – | – |
-217,171
| Closed | -$1.39M |
|
52
Ceragon Networks
CRNT
$189M
| – | – |
-670,158
| Closed | -$1.23M |
|
|
53
Castle Biosciences
CSTL
$988M
| – | – |
-63,345
| Closed | -$1.65M |
|
54
Dycom Industries
DY
$9.27B
| – | – |
-7,266
| Closed | -$694K |
|
55
FIVE9
FIVN
$2.37B
| – | – |
-12,549
| Closed | -$941K |
|
|
56
Identive
INVE
$62.5M
| – | – |
-124,060
| Closed | -$1.56M |
|
57
Omnicell
OMCL
$1.53B
| – | – |
-11,354
| Closed | -$988K |
|
58
Bank OZK
OZK
$5.35B
| – | – |
-9,801
| Closed | -$388K |
|
59
Porch Group
PRCH
$1.88B
| – | – |
-515,365
| Closed | -$1.16M |
|
60
Papa John's
PZZA
$718M
| – | – |
-5,020
| Closed | -$351K |
|
61
Rapid7
RPD
$862M
| – | – |
-19,721
| Closed | -$846K |
|
62
Veracyte
VCYT
$3.31B
| – | – |
-65,735
| Closed | -$1.09M |
|
|
EGIO
63
DELISTED
Edgio, Inc. Common Stock
EGIO
| – | – |
-8,444
| Closed | -$939K |
|
|
DMTK
64
DELISTED
DermTech, Inc. Common Stock
DMTK
| – | – |
-209,158
| Closed | -$828K |
|
|
CAMP
65
DELISTED
CalAmp Corp.
CAMP
| – | – |
-9,482
| Closed | -$837K |
|
|
LFG
66
DELISTED
Archaea Energy Inc.
LFG
| – | – |
-77,687
| Closed | -$1.4M |
|
Similar funds
SAM
ASGS
AIM
IG
G1
BGI
CM
SC
Millrace Asset Group's Q4 2022 Portfolio in Review
As of Q4 2022, Millrace Asset Group held 66 positions worth $88.1M, up 11% from $79.2M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Millrace Asset Group deployed $2.94M of net new capital in Q4 2022, opening 14 new positions and adding to 20 existing holdings. Its largest new stake was Tandem Diabetes Care: 56,211 shares worth $2.53M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Champions Oncology, an estimated $999K trimmed.
- Millrace Asset Group's largest Q4 2022 buy was Tandem Diabetes Care: 56,211 shares worth $2.53M.
- Millrace Asset Group added most to AXT Inc in Q4 2022, an estimated $1.43M increase.
- Millrace Asset Group's biggest Q4 2022 reduction was Champions Oncology, cutting an estimated $999K.
- Millrace Asset Group fully exited Castle Biosciences in Q4 2022, selling an estimated $1.65M.
- Millrace Asset Group's ten largest holdings make up 40% of its $88.1M portfolio in Q4 2022.
- Millrace Asset Group opened 14 new positions and closed 18 in Q4 2022.
- Millrace Asset Group's portfolio value rose 11% quarter-over-quarter to $88.1M.
Based on Millrace Asset Group's 13F filing for Q4 2022, filed 13 Feb 2023.